9EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein Ⅱb/Ⅲa receptor in highrisk coronary angioplasty. N Engl J Med, 1994, 330: 956-961.
10The IMPACT Ⅱ Investigators Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-Ⅱ. Lancet,1997, 349: 1422-1428.